Artiva Biotherapeutics, Inc. 4

Director Daniel G. Baker was granted a stock option for 13,750 shares of Artiva Biotherapeutics, Inc. common stock at $10.88 per share.

On September 8, 2026, Director Daniel G. Baker received a stock option award from Artiva Biotherapeutics, Inc. covering 13,750 shares of common stock at an exercise price of $10.88 per share, with the option scheduled to vest in full on the earlier of September 8, 2027 or the company’s 2027 annual stockholder meeting and expiring on September 7, 2036; following this grant, Baker beneficially owned 13,750 shares (all subject to the option).

Filing Facts

CIK

1817241

Ticker

ARTV

Form

4

Source Type

fda

Accession

0001193125-26-385412

Alert Tier

5